FBTAX
Price
$31.26
Change
+$0.55 (+1.79%)
Updated
Sep 5 closing price
Net Assets
1.46B
RYCFX
Price
$45.31
Change
+$0.80 (+1.80%)
Updated
Sep 5 closing price
Net Assets
90.4M
Interact to see
Advertisement

FBTAX vs RYCFX

Header iconFBTAX vs RYCFX Comparison
Open Charts FBTAX vs RYCFXBanner chart's image
Fidelity Advisor Biotechnology A
Price$31.26
Change+$0.55 (+1.79%)
VolumeN/A
Net Assets1.46B
Rydex Biotechnology C
Price$45.31
Change+$0.80 (+1.80%)
VolumeN/A
Net Assets90.4M
FBTAX vs RYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. RYCFX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and RYCFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. RYCFX (90.4M). FBTAX pays higher dividends than RYCFX: FBTAX (2.59) vs RYCFX (0.00). FBTAX was incepted earlier than RYCFX: FBTAX (25 years) vs RYCFX (24 years). RYCFX (2.43) is less costly to investors than FBTAX (0.96). RYCFX is a more actively managed with annual turnover of: 79.00 vs. FBTAX (73.00). FBTAX has a lower initial minimum investment than RYCFX: FBTAX (0) vs RYCFX (2500). FBTAX annual gain was more profitable for investors over the last year : -2.11 vs. RYCFX (-16.62). FBTAX return over 5 years is better than : 8.83 vs. RYCFX (-33.36).
FBTAXRYCFXFBTAX / RYCFX
Total Expense Ratio0.962.3840%
Annual Report Gross Expense Ratio0.962.4340%
Fund Existence25 years24 years-
Gain YTD14.88411.574129%
Front Load6%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B90.4M1,617%
Annual Yield % from dividends2.590.00-
Returns for 1 year-2.11-16.6213%
Returns for 3 years38.33-0.83-4,609%
Returns for 5 years8.83-33.36-26%
Returns for 10 years12.49-44.61-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOVF0.13N/A
+3.89%
SERNOVA BIOTHERAPEUTICS INC.
WXXWY9.350.19
+2.07%
Wuxi Biologics (Cayman) Inc
BWEL507.000.75
+0.15%
Boswell (J.G.) Co.
HAPVD10.01N/A
N/A
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA
AXVEF0.18N/A
N/A
CDN MAVERICK CAP CORP.